000 01268 a2200397 4500
005 20250511125445.0
264 0 _c19770321
008 197703s 0 0 eng d
022 _a0009-9236
024 7 _a10.1002/cpt19772119
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVlachakis, N D
245 0 0 _aAntihypertensive effects of tolamolol.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cJan 1977
300 _a9-15 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAntihypertensive Agents
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aBody Weight
_xdrug effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPropanolamines
_xadverse effects
650 0 4 _aRenin
_xblood
650 0 4 _aTime Factors
700 1 _aMendlowitz, M
700 1 _aKrakoff, L R
773 0 _tClinical pharmacology and therapeutics
_gvol. 21
_gno. 1
_gp. 9-15
856 4 0 _uhttps://doi.org/10.1002/cpt19772119
_zAvailable from publisher's website
999 _c344192
_d344192